NCT03880123 2020-11-27
Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma
Columbia University
Phase 1 Withdrawn
Clinical Trials
4 trialsNCT03888534 2020-09-28
Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy)
Takeda
Phase 1 Withdrawn
NCT02578511 2018-02-15
Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)
Medical College of Wisconsin
Phase 1 Withdrawn
NCT03422874 2018-02-06
Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma
Dartmouth-Hitchcock Medical Center
Phase 1 Withdrawn